Bladder cancer is more than three times more likely to occur in men than in women, with the risk for men being 1 in 27 and 1 in 84 for women. Nearly 90 percent of people with bladder cancer are age 55 or older.
At Martha Jefferson, a multidisciplinary and multi modality approach to bladder cancer provides patients with exceptional quality care and attention. Working together, urologists, medical oncologists and radiation oncologists develop robust treatment plans that have made Martha Jefferson's five-year survival rate for bladder cancer superior to state and national averages.
Bladder cancer typically presents as blood in the urine (hematuria), which usually triggers a referral to a urologist and possibly a biopsy. If biopsy confirms the presence of cancer, there are several treatment choices currently available at Martha Jefferson, which include: